134 related articles for article (PubMed ID: 7429297)
1. Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells.
Kemler BJ; Alpert E
Gut; 1980 May; 21(5):353-9. PubMed ID: 7429297
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. III. Serum factor modulates circulating and mucosal mononuclear-cell reactivity to epithelial cell-associated components of colon (ECAC-C).
Dunkel G; Paul JW; Roche JK
J Clin Immunol; 1987 Mar; 7(2):159-73. PubMed ID: 3571435
[TBL] [Abstract][Full Text] [Related]
3. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.
Gibson PR; van de Pol E; Pullman W; Doe WF
Gut; 1988 Aug; 29(8):1076-84. PubMed ID: 3261705
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells.
Stobo JD; Tomasi TB; Huizenga KA; Spencer RJ; Shorter RG
Gastroenterology; 1976 Feb; 70(2):171-6. PubMed ID: 1082423
[TBL] [Abstract][Full Text] [Related]
5. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro.
Roche JK; Fiocchi C; Youngman K
J Clin Invest; 1985 Feb; 75(2):522-30. PubMed ID: 3871793
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of mononuclear cells for autologous colonic epithelial cells in colonic diseases.
Shorter RG; McGill DB; Bahn RC
Gastroenterology; 1984 Jan; 86(1):13-22. PubMed ID: 6689655
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
Howat JM; Moore M; Hilton AM; Kimber I
Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic aspects of chronic inflammatory intestinal diseases].
Auer IO
Klin Padiatr; 1983; 195(5):337-41. PubMed ID: 6632712
[TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease.
Hirata I; Austin LL; Blackwell WH; Weber JR; Dobbins WO
Dig Dis Sci; 1986 Dec; 31(12):1317-30. PubMed ID: 3542442
[TBL] [Abstract][Full Text] [Related]
10. Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.
Snook JA; Lowes JR; Wu KC; Priddle JD; Jewell DP
Gut; 1991 Feb; 32(2):163-6. PubMed ID: 1864535
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in nonspecific inflammatory bowel disease (second of two parts).
Kirsner JB; Shorter RG
N Engl J Med; 1982 Apr; 306(14):837-48. PubMed ID: 7038490
[No Abstract] [Full Text] [Related]
12. Cd1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases.
Page MJ; Poritz LS; Tilberg AF; Zhang WJ; Chorney MJ; Koltun WA
J Surg Res; 2000 Aug; 92(2):214-21. PubMed ID: 10896824
[TBL] [Abstract][Full Text] [Related]
13. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.
Engstrom JF; Arvanitakis C; Sagawa A; Abdou NI
Gastroenterology; 1978 Apr; 74(4):747-51. PubMed ID: 415931
[TBL] [Abstract][Full Text] [Related]
14. Circulating Clq binding complexes in inflammatory bowel diseases.
Einstein E; Charland C; Thayer WR
Digestion; 1979; 19(1):65-9. PubMed ID: 456771
[TBL] [Abstract][Full Text] [Related]
15. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
Kemler BJ; Alpert E
Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathology of ulcerative colitis and granulomatous colitis (author's transl)].
Bläker F
Leber Magen Darm; 1975 Aug; 5(4):167-71. PubMed ID: 1223564
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients.
MacDermott RP; Kane MG; Steele LL; Stenson WF
Immunopharmacology; 1986 Apr; 11(2):101-9. PubMed ID: 2872186
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
Selby WS; Janossy G; Mason DY; Jewell DP
Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells.
Auer IO; Grosch L; Hardörfer C; Röder A
Gut; 1988 Dec; 29(12):1639-47. PubMed ID: 3220303
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
